Navigation Links
University of Minnesota licenses Clinical Decision Support technology

MINNEAPOLIS / ST. PAUL (07/10/2012) Clinical Decision Support technology developed by University of Minnesota researchers will enable healthcare providers to improve preventative care, communication and coordination among clinicians, researchers, and patients. Minneapolis-based startup Omicron Health Systems, Inc. will incorporate the technology in its Population Health Management offering to research networks and healthcare organizations.

Most patient record management systems available today predate the Internet and can be cumbersome to use. Many of the systems are built to serve administrative functions such as scheduling and billing, and are ill-equipped to support clinical decision-making or the sharing of data required to coordinate patient care.

Omicron Health's innovative solution, which incorporates the University technology, enables care providers and research networks to coordinate care delivery and research activities across clinics. Omicron Health provides a HIPAA-compliant platform that enables the secure transmission of patient health records and other data.

"This solution takes information out of an electronic record and reorganizes it to make it easier for a provider to use," says Kevin Peterson, the software inventor and a U of M professor of family medicine and community health. "It helps providers make better decisions about who needs medical care, and improves the ability of health care providers to identify when an individual is not getting medical care that could be important. The system standardizes information from electronic medical records, making it much easier to work with and to share between providers."

"Patients often see several doctors when they're sick and cross several organizational boundaries," says David DuChene, founder and CEO of Omicron Health. "Existing EHR systems were not designed to share data outside of the organization. With Omicron Health's solution, the patient's various providers are able to create a complete, shared medical record and coordinate their treatment to achieve the best result for the patient."

The University technology also helps ensure patients receive complete treatment. The system analyzes medical records and segments patients into groups according to their medical needs and helps clinicians monitor patient progress. Clinics can then reach out to patients with targeted treatments or preventative care.

Additionally, the technology will improve the process of performing clinical research by providing clinicians with the tools to automate patient identification, analysis, treatment monitoring, and performance reporting. These tools support real-time communication and coordination among distributed networks of researchers and their partner clinicians. This provides researchers with much more rapid and complete feedback from the clinicians administering the treatments and aids in the process of translating research to clinical application.

The University technology is also being implemented at the U of M's Clinical and Translational Science Institute to support research functions.

Contact: John Merritt
University of Minnesota

Related medicine news :

1. Scientists at the Mainz University Medical Center gain new insights into Taspase1 function
2. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
3. University of Louisville study dispels concerns about drive-thru flu clinics
4. Oxford University Press launches Evolution, Medicine, and Public Health
5. Wayne State University researcher seeks to understand link between obesity, flu severity
6. New £340,000 investment into asthma and allergy research at University of Leicester
7. University of Nevada School of Medicine researcher reviews muscular dystrophy therapies
8. Arizona State University secures defense contract
9. Wayne State University researcher examines proteins role in diabetic retinopathy
10. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
11. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... On November 10, 2015, Bohrer Brady, LLC filed a class ... of a home health care worker who provided companionship services for the elderly, ill ... employed by Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... people across the country to celebrate their sobriety and show through pictures what ... “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... physicians and athletic programs, launches new Wimbledon Athletics Facebook page to ... young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits of ... success Botox® delivers to those suffering with discomfort, soreness, and pain as a result ...
(Date:11/25/2015)... IL (PRWEB) , ... November 25, 2015 , ... ... to six decades of music, friendships, and learning in its 65th Anniversary Brillianteen ... held Dec. 5-6. , For 65 years, Brillianteen has been a ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)...  ARKRAY USA , Inc., a ... demonstrating the accuracy of its blood glucose meter systems. ... Diabetes and Cardiovascular Disease in Los Angeles ... ® 01 meter and the Assure ® ... to accurately measure glucose levels in blood is essential ...
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
Breaking Medicine Technology: